TGEN Tecogen Inc

Targeted Genetics Corporation (Nasdaq:TGEN) today announced that management will present a corporate overview, including an update to its product development programs and recent corporate activities, at the 8th Annual BIO CEO & Investor Conference on Tuesday, February 14, 2006 at 11:00 a.m. ET at the Waldorf-Astoria in New York. A live audio webcast of this presentation will be available on homepage of the company's website, www.targetedgenetics.com. The audio presentation and slideshow will be available for replay approximately three hours following the event and will be archived for 90 days. About Targeted Genetics Targeted Genetics Corporation is a biotechnology company committed to the development and commercialization of innovative targeted molecular therapies for the prevention and treatment of inflammatory arthritis, HIV/AIDS and other acquired and inherited diseases with significant unmet medical need. Targeted Genetics uses its considerable knowledge and capabilities in the development and manufacturing of gene delivery technologies to advance a diverse product development pipeline. Its product development efforts target inflammatory arthritis, HIV/AIDS, congestive heart failure, Huntington's disease, and hyperlipidemia. To learn more about Targeted Genetics, visit its website at www.targetedgenetics.com.